Literature DB >> 26772795

Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction.

Niklas Schofer1, Fabian J Brunner1, Michael Schlüter1, Francisco Ojeda1, Tanja Zeller1, Stephan Baldus2, Christoph Bickel3, Karl J Lackner4, Thomas Münzel5, Stergios Tzikas5,6, Sabine Genth-Zotz7, Ascan Warnholtz8, Felix Post5,7, Till Keller9, Britta U Goldmann1,10, Stefan Blankenberg1.   

Abstract

BACKGROUND: The determination of cardiac troponin is essential for diagnosing myocardial infarction. A troponin I assay has recently been developed that provides the highest analytical sensitivity to date.
METHODS: The analysis included 1560 patients with chest pain, of whom 1098 were diagnosed with non-coronary chest pain, 189 with unstable angina pectoris and 273 with non-ST-segment elevation myocardial infarction. The troponin I concentration was determined on admission (0 hours) and 3 hours later. The diagnostic algorithm incorporated troponin I elevation above the gender-specific 99th percentile as well as predefined relative or absolute 3-hour changes in the troponin I concentration (delta).
RESULTS: The diagnostic criterion of troponin I above the 99th percentile resulted in a negative predictive value of 98.0% and 98.2% in men and women, respectively. For rule-in of non-ST-segment elevation myocardial infarction, the use of absolute deltas yielded higher positive predictive values and sensitivities compared to relative deltas. With detection rates of about 85% and 82% in men and women, respectively, non-ST-segment elevation myocardial infarction was diagnosed with a positive predictive value close to 84% in men and 80% in women.
CONCLUSIONS: The investigational troponin I assay provides an excellent non-ST-segment elevation myocardial infarction rule out. With gender-specific differences, the application of absolute changes in troponin concentration was superior to relative changes to rule in patients with non-ST-segment elevation myocardial infarction.

Entities:  

Keywords:  Non-ST-segment elevation myocardial infarction; acute myocardial infarction; cardiac troponin; diagnostic performance; gender-specific; high-sensitivity

Mesh:

Substances:

Year:  2016        PMID: 26772795     DOI: 10.1177/2048872615626660

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  4 in total

Review 1.  Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease.

Authors:  Gerard Pasterkamp; Hester M den Ruijter; Peter Libby
Journal:  Nat Rev Cardiol       Date:  2016-10-20       Impact factor: 32.419

Review 2.  Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women.

Authors:  Anoop S V Shah; Amy V Ferry; Nicholas L Mills
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

3.  Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain.

Authors:  Jes-Niels Boeckel; Lars Palapies; Jens Klotsche; Tanja Zeller; Beatrice von Jeinsen; Maya F Perret; Soeren L Kleinhaus; Lars Pieper; Stergios Tzikas; David Leistner; Christoph Bickel; Günter K Stalla; Hendrik Lehnert; Bertil Lindahl; Hans-Ulrich Wittchen; Sigmund Silber; Stephan Baldus; Winfried Maerz; Stefanie Dimmeler; Stefan Blankenberg; Thomas Münzel; Andreas M Zeiher; Till Keller
Journal:  Sci Rep       Date:  2018-05-24       Impact factor: 4.379

4.  High Sensitivity Cardiac Troponin Assays - How to Implement them Successfully.

Authors:  Frederick K Korley; Allan S Jaffe
Journal:  EJIFCC       Date:  2016-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.